• Empowering you with objective information to assess pulmonary nodules.

  • Potentially avoiding biopsy or surgery – a reason to smile.

  • Simultaneously measures multiple proteins associated with lung cancer.

Xpresys Lung

Xpresys Lung is a molecular blood test developed to provide non-invasive, objective information for assessment of pulmonary nodules. When combined with current clinical assessment, Xpresys Lung may be able to help reduce unnecessary invasive procedures. By reducing these, our objectives are to improve patient outcomes, reduce complications, and lessen the cost to the healthcare system.

Learn more

Xpresys Lung is not affected by age, smoking history, gender, nodule size or nodule location, and COPD diagnosis. (1)

1. Vachani, Anil, MD. "Validation of a Multi-Protein Plasma Classifier to Identify Benign Lung Nodules: Journal of Thoracic Oncology." LWW. Journal of Thoracic Oncology, 14 Jan. 2015. Web. 26 Jan. 2015.

Upcoming Events

March 4

February 17
Molecular Med TRI-CON 2015
Speaker: Dr. Albert A. Luderer

View all events

About Indi

Indi is creating powerful new tools to help physicians diagnose complex diseases with a non-invasive blood test. By measuring multiple biomarkers that serve as sentinels of disease – we are creating tests that help physicians diagnose disease states with greater accuracy.

Learn more

Good Work

Join Our Mailing List:

Phone: 206.576.6300

Fax: 206.576.6350


Xpresys Lung

Customer Support Phone:

855.977.3797 or 855.XPRESYS

Email: info@indidx.com

Follow Us

You are now leaving this website. If you would like to continue, click Continue.
Cancel Continue